APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Therapy Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endocrine Therapy Medication Market Analysis and Forecast 2026-2032

27 December 2025211 pages

Choose your research edition.

Industry ResearchEndocrine Therapy Medication Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Therapy Medication Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Endocrine Therapy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Therapy Medication Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Therapy Medication Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Endocrine Therapy Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endocrine Therapy Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endocrine Therapy Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endocrine Therapy Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endocrine Therapy Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Endocrine Therapy Medication include Chongqing Laimi Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd. and Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endocrine Therapy Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endocrine Therapy Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Endocrine Therapy Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endocrine Therapy Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endocrine Therapy Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endocrine Therapy Medication sales, projected growth trends, production technology, application and end-user industry.

Endocrine Therapy Medication Segment by Company

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhongpeptide Biochemical Co., Ltd.

Zhejiang Haizhou Pharmaceutical Co., Ltd.

Zhejiang Haizheng Pharmaceutical Co., Ltd.

Changchun Jinsai Pharmaceutical Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

Shenzhen Hanyu Pharmaceutical Co., Ltd.

Shanghai Lizhu Pharmaceutical Co., Ltd.

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Maanshan Fengyuan Pharmaceutical Co., Ltd.

Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Good Doctor Pharmaceutical Group Co., Ltd.

Dandong Yichuang Pharmaceutical Co., Ltd.

Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Beijing Bornte Pharmaceutical Co., Ltd.

Teva

Pfizer

Janssen Biotech

Eli Lilly and Company

Dr. Reddy's

Cougar Biotechnology, Inc.

AstraZeneca

Endocrine Therapy Medication Segment by Type

Hormones and Related Drugs

Hormone Antagonists and Related Drugs

Endocrine Therapy Medication Segment by Application

Hospital

Clinic

Other

Endocrine Therapy Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Endocrine Therapy Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Endocrine Therapy Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Therapy Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrine Therapy Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hormones and Related Drugs Major Manufacturers Table 3. Hormone Antagonists and Related Drugs Major Manufacturers Table 4. Global Endocrine Therapy Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Endocrine Therapy Medication Industry Trends Table 9. Endocrine Therapy Medication Industry Drivers Table 10. Endocrine Therapy Medication Industry Opportunities and Challenges Table 11. Endocrine Therapy Medication Industry Restraints Table 12. Global Endocrine Therapy Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Endocrine Therapy Medication Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Endocrine Therapy Medication Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2026) Table 16. Global Endocrine Therapy Medication Revenue Market Share by Region (2027-2032) Table 17. Global Endocrine Therapy Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Endocrine Therapy Medication Sales by Region (2021-2026) & (K Units) Table 19. Global Endocrine Therapy Medication Sales by Region (2027-2032) & (K Units) Table 20. Global Endocrine Therapy Medication Sales Market Share by Region (2021-2026) Table 21. Global Endocrine Therapy Medication Sales Market Share by Region (2027-2032) Table 22. Global Endocrine Therapy Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Endocrine Therapy Medication Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Endocrine Therapy Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Endocrine Therapy Medication Sales Market Share by Manufacturers (2021-2026) Table 26. Global Endocrine Therapy Medication Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Endocrine Therapy Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Endocrine Therapy Medication Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Endocrine Therapy Medication Manufacturers, Product Type & Application Table 30. Global Endocrine Therapy Medication Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Endocrine Therapy Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Endocrine Therapy Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2026) Table 37. Global Endocrine Therapy Medication Revenue Market Share by Type (2027-2032) Table 38. Global Endocrine Therapy Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 40. Global Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 41. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2026) Table 42. Global Endocrine Therapy Medication Sales Market Share by Type (2027-2032) Table 43. Global Endocrine Therapy Medication Price by Type (2021-2026) & (US$/Unit) Table 44. Global Endocrine Therapy Medication Price by Type (2027-2032) & (US$/Unit) Table 45. Global Endocrine Therapy Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2026) Table 49. Global Endocrine Therapy Medication Revenue Market Share by Application (2027-2032) Table 50. Global Endocrine Therapy Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 52. Global Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 53. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2026) Table 54. Global Endocrine Therapy Medication Sales Market Share by Application (2027-2032) Table 55. Global Endocrine Therapy Medication Price by Application (2021-2026) & (US$/Unit) Table 56. Global Endocrine Therapy Medication Price by Application (2027-2032) & (US$/Unit) Table 57. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 58. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 59. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 61. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 62. Zhongpeptide Biochemical Co., Ltd. Company Information Table 63. Zhongpeptide Biochemical Co., Ltd. Business Overview Table 64. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 66. Zhongpeptide Biochemical Co., Ltd. Recent Development Table 67. Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information Table 68. Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview Table 69. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 71. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Development Table 72. Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information Table 73. Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview Table 74. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 76. Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Development Table 77. Changchun Jinsai Pharmaceutical Co., Ltd. Company Information Table 78. Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview Table 79. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 81. Changchun Jinsai Pharmaceutical Co., Ltd. Recent Development Table 82. Yangtze River Pharmaceutical Group Co., Ltd. Company Information Table 83. Yangtze River Pharmaceutical Group Co., Ltd. Business Overview Table 84. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 86. Yangtze River Pharmaceutical Group Co., Ltd. Recent Development Table 87. Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information Table 88. Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview Table 89. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 91. Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Development Table 92. Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information Table 93. Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview Table 94. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 96. Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Development Table 97. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information Table 98. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview Table 99. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 101. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Development Table 102. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 103. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 104. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 106. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 107. Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information Table 108. Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview Table 109. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 111. Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Development Table 112. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information Table 113. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview Table 114. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 116. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Development Table 117. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information Table 118. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview Table 119. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 121. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Development Table 122. Good Doctor Pharmaceutical Group Co., Ltd. Company Information Table 123. Good Doctor Pharmaceutical Group Co., Ltd. Business Overview Table 124. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 126. Good Doctor Pharmaceutical Group Co., Ltd. Recent Development Table 127. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information Table 128. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview Table 129. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 131. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Development Table 132. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information Table 133. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview Table 134. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 136. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Development Table 137. Beijing Bornte Pharmaceutical Co., Ltd. Company Information Table 138. Beijing Bornte Pharmaceutical Co., Ltd. Business Overview Table 139. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 141. Beijing Bornte Pharmaceutical Co., Ltd. Recent Development Table 142. Teva Company Information Table 143. Teva Business Overview Table 144. Teva Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Teva Endocrine Therapy Medication Product Portfolio Table 146. Teva Recent Development Table 147. Pfizer Company Information Table 148. Pfizer Business Overview Table 149. Pfizer Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Pfizer Endocrine Therapy Medication Product Portfolio Table 151. Pfizer Recent Development Table 152. Janssen Biotech Company Information Table 153. Janssen Biotech Business Overview Table 154. Janssen Biotech Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Janssen Biotech Endocrine Therapy Medication Product Portfolio Table 156. Janssen Biotech Recent Development Table 157. Eli Lilly and Company Company Information Table 158. Eli Lilly and Company Business Overview Table 159. Eli Lilly and Company Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Eli Lilly and Company Endocrine Therapy Medication Product Portfolio Table 161. Eli Lilly and Company Recent Development Table 162. Dr. Reddy's Company Information Table 163. Dr. Reddy's Business Overview Table 164. Dr. Reddy's Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Dr. Reddy's Endocrine Therapy Medication Product Portfolio Table 166. Dr. Reddy's Recent Development Table 167. Cougar Biotechnology, Inc. Company Information Table 168. Cougar Biotechnology, Inc. Business Overview Table 169. Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio Table 171. Cougar Biotechnology, Inc. Recent Development Table 172. AstraZeneca Company Information Table 173. AstraZeneca Business Overview Table 174. AstraZeneca Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. AstraZeneca Endocrine Therapy Medication Product Portfolio Table 176. AstraZeneca Recent Development Table 177. North America Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 178. North America Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 179. North America Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 180. North America Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 181. North America Endocrine Therapy Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 182. North America Endocrine Therapy Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 183. North America Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 184. North America Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 185. North America Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 186. North America Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 187. North America Endocrine Therapy Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 188. North America Endocrine Therapy Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 189. North America Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. North America Endocrine Therapy Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. North America Endocrine Therapy Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. North America Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. North America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 194. North America Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units) Table 195. North America Endocrine Therapy Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 196. North America Endocrine Therapy Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 197. United States Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 198. Canada Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 199. Mexico Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 200. Europe Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 201. Europe Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 202. Europe Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 203. Europe Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 204. Europe Endocrine Therapy Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Europe Endocrine Therapy Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Europe Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 209. Europe Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 210. Europe Endocrine Therapy Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Europe Endocrine Therapy Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Europe Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Europe Endocrine Therapy Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Europe Endocrine Therapy Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Europe Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Europe Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 217. Europe Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units) Table 218. Europe Endocrine Therapy Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Europe Endocrine Therapy Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Germany Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 221. France Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 222. U.K. Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 223. Italy Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 224. Russia Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 225. Spain Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 226. Netherlands Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 227. Switzerland Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 228. Sweden Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 229. Poland Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 230. China Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 231. China Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 232. China Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 233. China Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 234. China Endocrine Therapy Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 235. China Endocrine Therapy Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 236. China Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 237. China Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 238. China Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 239. China Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 240. China Endocrine Therapy Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 241. China Endocrine Therapy Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 242. Asia Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 243. Asia Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 244. Asia Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 245. Asia Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 246. Asia Endocrine Therapy Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 247. Asia Endocrine Therapy Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 248. Asia Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 249. Asia Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 250. Asia Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 251. Asia Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 252. Asia Endocrine Therapy Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 253. Asia Endocrine Therapy Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 254. Asia Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. Asia Endocrine Therapy Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. Asia Endocrine Therapy Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. Asia Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 258. Asia Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 259. Asia Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units) Table 260. Asia Endocrine Therapy Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 261. Asia Endocrine Therapy Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Japan Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 263. South Korea Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 264. India Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 265. Australia Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 266. Taiwan Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 267. Southeast Asia Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 268. SAMEA Endocrine Therapy Medication Revenue by Type (2021-2026) & (US$ Million) Table 269. SAMEA Endocrine Therapy Medication Revenue by Type (2027-2032) & (US$ Million) Table 270. SAMEA Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 271. SAMEA Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 272. SAMEA Endocrine Therapy Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 273. SAMEA Endocrine Therapy Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 274. SAMEA Endocrine Therapy Medication Revenue by Application (2021-2026) & (US$ Million) Table 275. SAMEA Endocrine Therapy Medication Revenue by Application (2027-2032) & (US$ Million) Table 276. SAMEA Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 277. SAMEA Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 278. SAMEA Endocrine Therapy Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 279. SAMEA Endocrine Therapy Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 280. SAMEA Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 281. SAMEA Endocrine Therapy Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 282. SAMEA Endocrine Therapy Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 283. SAMEA Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 284. SAMEA Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 285. SAMEA Endocrine Therapy Medication Sales by Country (2027-2032) & (K Units) Table 286. SAMEA Endocrine Therapy Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 287. SAMEA Endocrine Therapy Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 288. Brazil Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 289. Argentina Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 290. Chile Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 291. Colombia Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 292. Peru Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 293. Saudi Arabia Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 294. Israel Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 295. UAE Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 296. Turkey Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 297. Iran Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 298. Egypt Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Table 299. Key Raw Materials Table 300. Raw Materials Key Suppliers Table 301. Endocrine Therapy Medication Distributors List Table 302. Endocrine Therapy Medication Customers List Table 303. Research Programs/Design for This Report Table 304. Authors List of This Report Table 305. Secondary Sources Table 306. Primary Sources List of Figures Figure 1. Endocrine Therapy Medication Image Figure 2. Global Endocrine Therapy Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Therapy Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hormones and Related Drugs Image Figure 5. Hormone Antagonists and Related Drugs Image Figure 6. Global Endocrine Therapy Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Endocrine Therapy Medication Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Endocrine Therapy Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Endocrine Therapy Medication Revenue (2021-2032) & (US$ Million) Figure 13. Global Endocrine Therapy Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Endocrine Therapy Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2032) Figure 16. Global Endocrine Therapy Medication Sales (2021-2032) & (K Units) Figure 17. Global Endocrine Therapy Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Endocrine Therapy Medication Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Endocrine Therapy Medication Sales YoY (2021-2032) & (K Units) Figure 20. Europe Endocrine Therapy Medication Sales YoY (2021-2032) & (K Units) Figure 21. China Endocrine Therapy Medication Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Endocrine Therapy Medication Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Endocrine Therapy Medication Sales YoY (2021-2032) & (K Units) Figure 24. Global Endocrine Therapy Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Endocrine Therapy Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Endocrine Therapy Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Endocrine Therapy Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032) Figure 30. Global Endocrine Therapy Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Endocrine Therapy Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032) Figure 33. Global Endocrine Therapy Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Endocrine Therapy Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032) Figure 36. Global Endocrine Therapy Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Endocrine Therapy Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032) Figure 39. North America Endocrine Therapy Medication Revenue Share by Type (2021-2032) Figure 40. North America Endocrine Therapy Medication Sales Share by Type (2021-2032) Figure 41. North America Endocrine Therapy Medication Revenue Share by Application (2021-2032) Figure 42. North America Endocrine Therapy Medication Sales Share by Application (2021-2032) Figure 43. North America Endocrine Therapy Medication Revenue Share by Country (2021-2032) Figure 44. North America Endocrine Therapy Medication Sales Share by Country (2021-2032) Figure 45. Europe Endocrine Therapy Medication R

Scope & coverage.

Types
  • Hormones and Related Drugs
  • Hormone Antagonists and Related Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhongpeptide Biochemical Co., Ltd.
  • Zhejiang Haizhou Pharmaceutical Co., Ltd.
  • Zhejiang Haizheng Pharmaceutical Co., Ltd.
  • Changchun Jinsai Pharmaceutical Co., Ltd.
  • Yangtze River Pharmaceutical Group Co., Ltd.
  • Shenzhen Hanyu Pharmaceutical Co., Ltd.
  • Shanghai Lizhu Pharmaceutical Co., Ltd.
  • Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Maanshan Fengyuan Pharmaceutical Co., Ltd.
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  • Good Doctor Pharmaceutical Group Co., Ltd.
  • Dandong Yichuang Pharmaceutical Co., Ltd.
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  • Beijing Bornte Pharmaceutical Co., Ltd.
  • Teva
  • Pfizer
  • Janssen Biotech
  • Eli Lilly and Company
  • Dr. Reddy's
  • Cougar Biotechnology, Inc.
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endocrine Therapy Medication Market by Type
  3. 1.2.1 Global Endocrine Therapy Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hormones and Related Drugs
  5. 1.2.3 Hormone Antagonists and Related Drugs
  6. 1.3 Endocrine Therapy Medication Market by Application
  7. 1.3.1 Global Endocrine Therapy Medication Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Endocrine Therapy Medication Market Dynamics
  1. 2.1 Endocrine Therapy Medication Industry Trends
  2. 2.2 Endocrine Therapy Medication Industry Drivers
  3. 2.3 Endocrine Therapy Medication Industry Opportunities and Challenges
  4. 2.4 Endocrine Therapy Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Endocrine Therapy Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Endocrine Therapy Medication Revenue by Region
  3. 3.2.1 Global Endocrine Therapy Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endocrine Therapy Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Endocrine Therapy Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Endocrine Therapy Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Endocrine Therapy Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Endocrine Therapy Medication Sales by Region
  9. 3.4.1 Global Endocrine Therapy Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Endocrine Therapy Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Endocrine Therapy Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Endocrine Therapy Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Endocrine Therapy Medication Revenue by Manufacturers
  2. 4.1.1 Global Endocrine Therapy Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Endocrine Therapy Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Endocrine Therapy Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endocrine Therapy Medication Sales by Manufacturers
  6. 4.2.1 Global Endocrine Therapy Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Endocrine Therapy Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Endocrine Therapy Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Endocrine Therapy Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Endocrine Therapy Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Endocrine Therapy Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Endocrine Therapy Medication Manufacturers, Product Type & Application
  13. 4.7 Global Endocrine Therapy Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Endocrine Therapy Medication Market CR5 and HHI
  16. 4.8.2 2025 Endocrine Therapy Medication Tier 1, Tier 2, and Tier 3
5 Endocrine Therapy Medication Market by Type
  1. 5.1 Global Endocrine Therapy Medication Revenue by Type
  2. 5.1.1 Global Endocrine Therapy Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Endocrine Therapy Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Endocrine Therapy Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Endocrine Therapy Medication Sales by Type
  6. 5.2.1 Global Endocrine Therapy Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endocrine Therapy Medication Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Endocrine Therapy Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Endocrine Therapy Medication Price by Type
6 Endocrine Therapy Medication Market by Application
  1. 6.1 Global Endocrine Therapy Medication Revenue by Application
  2. 6.1.1 Global Endocrine Therapy Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Endocrine Therapy Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Endocrine Therapy Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Endocrine Therapy Medication Sales by Application
  6. 6.2.1 Global Endocrine Therapy Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Endocrine Therapy Medication Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Endocrine Therapy Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Endocrine Therapy Medication Price by Application
7 Company Profiles
  1. 7.1 Chongqing Laimi Pharmaceutical Co., Ltd.
  2. 7.1.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  6. 7.1.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Zhongpeptide Biochemical Co., Ltd.
  8. 7.2.1 Zhongpeptide Biochemical Co., Ltd. Company Information
  9. 7.2.2 Zhongpeptide Biochemical Co., Ltd. Business Overview
  10. 7.2.3 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  12. 7.2.5 Zhongpeptide Biochemical Co., Ltd. Recent Developments
  13. 7.3 Zhejiang Haizhou Pharmaceutical Co., Ltd.
  14. 7.3.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  18. 7.3.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Zhejiang Haizheng Pharmaceutical Co., Ltd.
  20. 7.4.1 Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  24. 7.4.5 Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Changchun Jinsai Pharmaceutical Co., Ltd.
  26. 7.5.1 Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  30. 7.5.5 Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Yangtze River Pharmaceutical Group Co., Ltd.
  32. 7.6.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
  33. 7.6.2 Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
  34. 7.6.3 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
  36. 7.6.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments
  37. 7.7 Shenzhen Hanyu Pharmaceutical Co., Ltd.
  38. 7.7.1 Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  42. 7.7.5 Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Shanghai Lizhu Pharmaceutical Co., Ltd.
  44. 7.8.1 Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  48. 7.8.5 Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
  50. 7.9.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  54. 7.9.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  56. 7.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  60. 7.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Maanshan Fengyuan Pharmaceutical Co., Ltd.
  62. 7.11.1 Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  66. 7.11.5 Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  68. 7.12.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  72. 7.12.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  74. 7.13.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  78. 7.13.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Good Doctor Pharmaceutical Group Co., Ltd.
  80. 7.14.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information
  81. 7.14.2 Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
  82. 7.14.3 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
  84. 7.14.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments
  85. 7.15 Dandong Yichuang Pharmaceutical Co., Ltd.
  86. 7.15.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  90. 7.15.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  92. 7.16.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  96. 7.16.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Beijing Bornte Pharmaceutical Co., Ltd.
  98. 7.17.1 Beijing Bornte Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  102. 7.17.5 Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Teva
  104. 7.18.1 Teva Company Information
  105. 7.18.2 Teva Business Overview
  106. 7.18.3 Teva Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Teva Endocrine Therapy Medication Product Portfolio
  108. 7.18.5 Teva Recent Developments
  109. 7.19 Pfizer
  110. 7.19.1 Pfizer Company Information
  111. 7.19.2 Pfizer Business Overview
  112. 7.19.3 Pfizer Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Pfizer Endocrine Therapy Medication Product Portfolio
  114. 7.19.5 Pfizer Recent Developments
  115. 7.20 Janssen Biotech
  116. 7.20.1 Janssen Biotech Company Information
  117. 7.20.2 Janssen Biotech Business Overview
  118. 7.20.3 Janssen Biotech Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Janssen Biotech Endocrine Therapy Medication Product Portfolio
  120. 7.20.5 Janssen Biotech Recent Developments
  121. 7.21 Eli Lilly and Company
  122. 7.21.1 Eli Lilly and Company Company Information
  123. 7.21.2 Eli Lilly and Company Business Overview
  124. 7.21.3 Eli Lilly and Company Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
  126. 7.21.5 Eli Lilly and Company Recent Developments
  127. 7.22 Dr. Reddy's
  128. 7.22.1 Dr. Reddy's Company Information
  129. 7.22.2 Dr. Reddy's Business Overview
  130. 7.22.3 Dr. Reddy's Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Dr. Reddy's Endocrine Therapy Medication Product Portfolio
  132. 7.22.5 Dr. Reddy's Recent Developments
  133. 7.23 Cougar Biotechnology, Inc.
  134. 7.23.1 Cougar Biotechnology, Inc. Company Information
  135. 7.23.2 Cougar Biotechnology, Inc. Business Overview
  136. 7.23.3 Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
  138. 7.23.5 Cougar Biotechnology, Inc. Recent Developments
  139. 7.24 AstraZeneca
  140. 7.24.1 AstraZeneca Company Information
  141. 7.24.2 AstraZeneca Business Overview
  142. 7.24.3 AstraZeneca Endocrine Therapy Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 AstraZeneca Endocrine Therapy Medication Product Portfolio
  144. 7.24.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America Endocrine Therapy Medication Market Size by Type
  2. 8.1.1 North America Endocrine Therapy Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Endocrine Therapy Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Endocrine Therapy Medication Price by Type (2021-2032)
  5. 8.2 North America Endocrine Therapy Medication Market Size by Application
  6. 8.2.1 North America Endocrine Therapy Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Endocrine Therapy Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Endocrine Therapy Medication Price by Application (2021-2032)
  9. 8.3 North America Endocrine Therapy Medication Market Size by Country
  10. 8.3.1 North America Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Endocrine Therapy Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Endocrine Therapy Medication Market Size by Type
  2. 9.1.1 Europe Endocrine Therapy Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Endocrine Therapy Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Endocrine Therapy Medication Price by Type (2021-2032)
  5. 9.2 Europe Endocrine Therapy Medication Market Size by Application
  6. 9.2.1 Europe Endocrine Therapy Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Endocrine Therapy Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Endocrine Therapy Medication Price by Application (2021-2032)
  9. 9.3 Europe Endocrine Therapy Medication Market Size by Country
  10. 9.3.1 Europe Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Endocrine Therapy Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Endocrine Therapy Medication Market Size by Type
  2. 10.1.1 China Endocrine Therapy Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Endocrine Therapy Medication Sales by Type (2021-2032)
  4. 10.1.3 China Endocrine Therapy Medication Price by Type (2021-2032)
  5. 10.2 China Endocrine Therapy Medication Market Size by Application
  6. 10.2.1 China Endocrine Therapy Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Endocrine Therapy Medication Sales by Application (2021-2032)
  8. 10.2.3 China Endocrine Therapy Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endocrine Therapy Medication Market Size by Type
  2. 11.1.1 Asia Endocrine Therapy Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Endocrine Therapy Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Endocrine Therapy Medication Price by Type (2021-2032)
  5. 11.2 Asia Endocrine Therapy Medication Market Size by Application
  6. 11.2.1 Asia Endocrine Therapy Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Endocrine Therapy Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Endocrine Therapy Medication Price by Application (2021-2032)
  9. 11.3 Asia Endocrine Therapy Medication Market Size by Country
  10. 11.3.1 Asia Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Endocrine Therapy Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endocrine Therapy Medication Market Size by Type
  2. 12.1.1 SAMEA Endocrine Therapy Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Endocrine Therapy Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Endocrine Therapy Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Endocrine Therapy Medication Market Size by Application
  6. 12.2.1 SAMEA Endocrine Therapy Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Endocrine Therapy Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Endocrine Therapy Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Endocrine Therapy Medication Market Size by Country
  10. 12.3.1 SAMEA Endocrine Therapy Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Endocrine Therapy Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Endocrine Therapy Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Endocrine Therapy Medication Value Chain Analysis
  2. 13.1.1 Endocrine Therapy Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Endocrine Therapy Medication Production Mode & Process
  6. 13.2 Endocrine Therapy Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Endocrine Therapy Medication Distributors
  9. 13.2.3 Endocrine Therapy Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst